期刊文献+

儿童颅外恶性生殖细胞性肿瘤诊断治疗方案临床报告 被引量:2

原文传递
导出
摘要 国际上通过多中心协作的临床研究使儿童恶性生殖细胞性肿瘤(GT)诊断治疗技术有了很大的进步,长期无病生存率已达60%-90%。但我国仍比较落后,诊断完整性及治疗过程的合理性仍有较大的欠缺,较为规范的诊断治疗疗效报告极少,为此我们综合国际上著名GT协作组的相关诊断治疗经验,结合我院实际情况,采用与儿童横纹肌肉瘤(RS)相似的化疗方案治疗儿童GT。
出处 《中华儿科杂志》 CAS CSCD 北大核心 2008年第5期388-389,共2页 Chinese Journal of Pediatrics
  • 相关文献

参考文献6

  • 1Steiner H, Muller T, Gozzi C, et al. Two cycles of cisplatin-based chemotherapy for low-volume retroperitoneal stage H nonseminomatous germ cell tumours. BJU Int, 2006, 98: 349- 352.
  • 2De Backer A, Madem GC, Oosterhuis JW, et at. Ovarian germ cell tumors in children: a clinical study of 66 patienta, Pediatr Blood Cancer, 2006, 46:459-464.
  • 3Dimopoulos MA, Papadimitriou C, Hamilos G, et al. Treatment of ovarian germ cell tumors with a 3-day bleomycin, etoposide, and cisplatin regimen: a prospective multicenter study. Gynecol Oncol, 2004,95:695-700.
  • 4Billmire D, Vinocur C, Rescorla F, et al. Outcome and staging evaluation in malignant germ cell rumors of the ovary in children and adolescents: an intergroup study. J Pediatr Surg, 2004,39: 424-429.
  • 5Rogers PC, Olson TA, Cullen JW, et at. Treatment of children and adolescents with stage Ⅱ testicular and stages Ⅰ and Ⅱ ovarian malignant germ cell tumors: a pediatric intergroup study-pediatric oncology group 9048 and children's cancer group 8891. J Clin Oncol, 2004, 22:3563-3569.
  • 6Miki T, Mizutani Y, Akaza H, et aL Long-term results of firstline sequential high-dose carboplatin, etopeside and ifosfamide chemotherapy with peripheral blood stem cell support for patients with advanced testicular germ cell tumor. Int J Urol, 2007,14:54- 59.

同被引文献25

  • 1汤静燕,潘慈,陈静,徐敏,薛惠良,顾龙君,董茹,叶辉,周敏,王耀平.45例儿童神经母细胞瘤预后因素分析[J].中华儿科杂志,2006,44(10):770-773. 被引量:21
  • 2孙晓非,杨群英,甄子俊,夏奕,王智辉,凌家瑜.44例儿童青少年恶性生殖细胞肿瘤综合治疗结果分析[J].癌症,2006,25(12):1529-1532. 被引量:9
  • 3黄钢,刘剑帆,徐学政,李林勤.新辅助化疗治疗儿童骨肉瘤[J].医学临床研究,2007,24(3):423-425. 被引量:4
  • 4van de Geijn GJ, Hersmus R, Looijenga LH. Recent developments in testicular germ cell tumor research [J]. Birth Defects Res C Embryo Today, 2009,87 ( 1 ) : 96-113.
  • 5Gilbert DC, van As NJ, Huddart RA, et al. Reducing treatment toxicities in the management of good prognosis testicular germ cell tumors [J]. Expert Rev Anticancer Ther, 2009,9(2): 223-233.
  • 6Cushing B, Giller R, Cullen JW, et al. Randomized comparison of combination chemotherapy with etoposide, bleomycin, and either high-dose or stangard-dose cisplatin in children and adolescents with high-risk malignant germ cell tumors: a pediatric intergroup study-Pediatric Ontology Group 9049 and Children's Cancer Group 8882 [J]. J Clin Oncol,2004,22(13):2691-2700.
  • 7Park JR, Scott JR, Stewart CF, et al, Pilot induction regimen incor- porating pharmacokineticaUy guided topotecan for treatment of newly diagnosed high-risk neuroblastoma: a Children's Oncology Group study[J].J Clin Oncol, 2011, 29(33): 4351-4357.
  • 8Castel V, TovarJA, Costa E, et al. The role of surgery in stage IV neuroblastoma[J].J Pediatr Surg, 2002, 37 (11): 1547-1578.
  • 9Bastian PJ, Fleischhack G, Zimmermann M, et al. The role ot com- plete surgical resection in stage IV Neuroblastoma[J]. WorldJ Urol, 2004, 22(4):257-260.
  • 10Bamias A, Aravantinos G, Kastriotis I, et al. Report of the long-term efficacy of two cycles of adjuvant bleomycin/etoposide/ cisplatin in patients with stage I testicular nonseminomatous germ-cell tumors (NSGCT) : a risk adapted protocol of the Hellen- ic Cooperative Oncology Group[J]. Urol Oncol, 2011, 29(2): 189-193.

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部